AMC Holdings arranges for leading U.S. researchers, academic institutions and physicians to join existing clinical trials performed by leading biotech and pharmaceutical manufacturers abroad, and establish U.S. based trials for promising bio-pharmaceutical products that meet our three key criteria:
What We Do
Marketing and Distribution of Innovative Bio-Pharmaceutical Products
- Address disease management for pressing healthcare needs that have proven intractable and expensive with existing treatments or protocols
- Offer botanical or bio-pharmaceutical solutions where none exists, or as alternatives to existing medications, without the negative side effects that can affect a patient’s quality of life
- Offer the prospect of expanding access to novel treatments with lower cost alternatives to existing drugs or protocols
Regulatory Approvals and Compliance
AMC works with researchers and healthcare providers to join existing trials, establish new trials, and secure regulatory approval from state and federal agencies.
We assist institutions and providers seeking to import, test, distribute or prescribe innovative bio-pharmaceutical products. We are committed to the highest level safety and compliance when it comes to testing, manufacturing and transferring of products to the U.S. Market.
We import MGC Pharmaceutical’s products from GMP “Pharmaceutical” Certified plants, and follow the strict U.S. FDA and U.S. DEA guidelines for importation, transportation, storage and administration of Pharmaceutical products.
Clinical Trials and Meta-Data Collection
Our team works with leading U.S. universities, doctors and healthcare systems who seek to join or establish Stage IIb and Stage III trials of bio-pharmaceutical products. AMC will supply ground-breaking medicines to patients whose physicians are actively participating in the meta-data gathering and analysis.
Clinical trials of MGC Pharmaceutical’s products cover 6 continents. AMC assists US researchers, clinicians and patients who wish to participate in those trials, start their own, or learn more about related studies.
For information regarding on-going clinical trials in the U.S. and abroad, check our site for updates.
Through its partnership with MGC Pharmaceuticals, Inc., AMC Holdings will focus on the following products on the positioning of the following products, for which U.S. trials are in process or to commence 2021:
US Doctors and Patients participate in International trials under agreements between the EU and US
AMC is working with leading U.S. Research Institutions to join international trials and register U.S. based clinical trials.
News on trials will be regularly updated here: How to join, how to sponsor and how to participate.
US Based Trials Begin 2021
MGC and AMC are participating in, sponsoring or organizing the following US based trials:
For Inquiries Regarding the AMC- MGC Agreement
Please Contact: Brent Yessin, VP General Counsel
AMC Holdings, Inc. Legal Affairs
201 E. Kennedy Blvd., Suite 1611, Tampa, Florida 33602, United States